Q192-193: Disease Status at the Last Evaluation Prior to the Start of the Preparative Regimen / Infusion

Question 192: What was the disease status at the last evaluation prior to the start of the preparative regimen?

*Nodular Partial Response
Nodular partial response (nPR) is a listed disease status option on the Pre-TED Form (Form 2400), but not on the CLL Pre- and Post-HCT Data Forms (Form 2013 and 2113). If the disease status meets the criteria for nPR, report the disease status as partial response (PR) on Forms 2013 and 2113.

Indicate the disease status using the international working group criteria provided in CLL Response Criteria section of the Forms Instructions Manual. The pre-HCT disease status is determined by a disease assessment, such as hematologic testing, pathology study, and/or physician assessment.

If no chemotherapy was given within 6 months of the start of the preparative regimen, report “Untreated.”

If the best response to the line of therapy was not evaluated, report “not assessed (NA)” and skip question 193.

If the best response to the line of therapy is unknown, report “unknown” and skip question 193.

Question 193: Date of the most recent assessment for disease status prior to the preparative regimen

Enter the date of the most recent assessment of disease status prior to the start of the preparative regimen. Report the date of the pathologic evaluation (e.g., bone marrow biopsy), radiographic examination (e.g., X-rays, CT scans, MRI scans, PET scans), or blood/serum assessment (e.g., CBC, peripheral blood smear). Enter the date the sample was collected for pathologic and laboratory evaluations; enter the date the imaging took place for radiographic assessments. If no pathologic, radiographic, or laboratory assessment was performed within the pre-transplant work-up time period, report the most recent office visit in which the physician assessed the recipient’s disease status.

If the exact date is not known, use the process described for reporting partial or unknown dates in General Instructions, General Guidelines for Completing Forms.

Section Updates:

Question Number	Date of Change	Add/Remove/Modify	Description	Reasoning (If applicable)
.	.	.	.	.

Copyright © 2004-2024 The Medical College of Wisconsin, Inc. and NMDP. All Rights Reserved.
CIBMTR® (Center for International Blood and Marrow Transplant Research) is a research collaboration between the Medical College of Wisconsin and NMDP.